Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Refers to a common packaging format for birth control pills containing both active hormone-containing pills (with progesterone or a progestin) and hormone-free placebo pills. Typically, a pack includes 21 active pills and 7 placebo pills, or 21 active pills followed by a 7-day pill-free interval (equivalent to a placebo period). The placebo pills are included to allow for a withdrawal bleed (menstruation) during the placebo period. Progesterone (or progestin) in birth control works by preventing pregnancy through several mechanisms: * Inhibiting ovulation * Thickening cervical mucus, making it difficult for sperm to reach the uterus * Altering the uterine lining (endometrium) to prevent implantation While many combination birth control pills contain both estrogen and a progestin, there are also progestin-only pills that utilize this placebo packaging format.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Progesterone with placebo.